Lung cancer is one of the most common cancers in the world—and cigarette smoking causes most lung cancers. Lung cancer is characterized by uncontrolled cell growth in tissues of the lung. Between 30 and 65 percent of early-stage lung cancer patients will die within five years. In comparison, only between 10 and 25 percent of early-stage breast cancer patients will die within the same timespan.
Doctors use standard guidelines to determine treatment, but the problem is that these guidelines are based on limited data and fail to account for the whole picture. Guidelines use stage of cancer to evaluate treatment options, but treatments based on stage alone can lead to suboptimal treatment recommendations. Since no two cancers are alike, treatments must become more personalized. Stage as well as CCP may lead to better risk measurement when determining treatment options. myPlan Lung Cancer is a test based on CCP genes—it measures how fast lung cancer cells are replicating. This gives a clearer picture of the risk or likelihood of death for a 5-year period.
To learn more, check out the infographic below presented by Myriad.